Gene · 3732
Papers4,224
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 4,224
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| G0S2 regulates innate immunity in Kawasaki disease via lncRNA HSD11B1-AS1. | Pediatr Res | 2022 | 35292727 | PubTator, text mining | PubMed |
| Regulation of miR-30b in cancer development, apoptosis, and drug resistance. | Open Life Sci | 2022 | 35291564 | PubTator, text mining | PubMed |
| Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications. | J Transl Med | 2022 | 35287692 | PubTator, text mining | PubMed |
| Adipose-Derived Extracellular Vesicles: Systemic Messengers and Metabolic Regulators in Health and Disease. | Front Physiol | 2022 | 35283789 | PubTator, text mining | PubMed |
| Tspan9 Induces EMT and Promotes Osteosarcoma Metastasis via Activating FAK-Ras-ERK1/2 Pathway. | Front Oncol | 2022 | 35280793 | PubTator, text mining | PubMed |
| Offshore wind power station (OWPS) site selection using a two-stage MCDM-based spherical fuzzy set approach. | Sci Rep | 2022 | 35277582 | PubTator, text mining | PubMed |
| Exosomes in multiple myeloma: from bench to bedside. | Blood | 2022 | 35271699 | PubTator, text mining | PubMed |
| Malnutrition and Biomarkers: A Journey through Extracellular Vesicles. | Nutrients | 2022 | 35267977 | PubTator, text mining | PubMed |
| An emerging role of radiation‑induced exosomes in hepatocellular carcinoma progression and radioresistance (Review). | Int J Oncol | 2022 | 35266016 | PubTator, text mining | PubMed |
| Tetraspanin CD9: A friend or foe of head and neck cancer (Review). | Oncol Rep | 2022 | 35266009 | PubTator, text mining | PubMed |
| Number and function of uterine natural killer cells in recurrent miscarriage and implantation failure: a systematic review and meta-analysis. | Hum Reprod Update | 2022 | 35265977 | PubTator, text mining | PubMed |
| Isolation and molecular characterization of circulating extracellular vesicles from blood of chronic Chagas disease patients. | Cell Biol Int | 2022 | 35253308 | PubTator, text mining | PubMed |
| Cell Surface Proteins for Enrichment and In Vitro Characterization of Human Pluripotent Stem Cell-Derived Myogenic Progenitors. | Stem Cells Int | 2022 | 35251185 | PubTator, text mining | PubMed |
| Nanomaterial-based biosensor developing as a route toward in vitro diagnosis of early ovarian cancer. | Mater Today Bio | 2022 | 35243293 | PubTator, text mining | PubMed |
| UXT, a novel DNMT3b-binding protein, promotes breast cancer progression via negatively modulating lncRNA MEG3/p53 axis. | Mol Ther Oncolytics | 2022 | 35229028 | PubTator, text mining | PubMed |
| Extracting Safety-II Factors From an Incident Reporting System by Text Analysis. | Cureus | 2022 | 35223303 | PubTator, text mining | PubMed |
| Zika Virus Infection of Sertoli Cells Alters Protein Expression Involved in Activated Immune and Antiviral Response Pathways, Carbohydrate Metabolism and Cardiovascular Disease. | Viruses | 2022 | 35215967 | PubTator, text mining | PubMed |
| Polymeric Coating of Silica Microspheres for Biological Applications: Suppression of Non-Specific Binding and Functionalization with Biomolecules. | Polymers (Basel) | 2022 | 35215642 | PubTator, text mining | PubMed |
| The Potential Application of Extracellular Vesicles from Liquid Biopsies for Determination of Pharmacogene Expression. | Pharmaceuticals (Basel) | 2022 | 35215364 | PubTator, text mining | PubMed |
| Exosomes and Other Extracellular Vesicles with High Therapeutic Potential: Their Applications in Oncology, Neurology, and Dermatology. | Molecules | 2022 | 35209095 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3732/papers?page=46